Mayo Clinic launches two joint ventures to build, commercialize diagnostic AI tools
Related Articles
Mayo Clinic helps launch two new companies for improved diagnostics
Mass Device: Mayo Clinic announced that it is introducing a new technology platform to support two new companies it has launched. Rochester, Minn.–based Mayo Clinic’s Remote Diagnostics & Management Platform…{post_date: F d, Y}
The Real Test for AI Diagnostics Isn’t Performance — It’s Clinical Adoption
Cardiology, in particular, offers a clear view into why so many AI solutions struggle to scale and what differentiates those that are poised for adoption. Across healthcare, AI-enabled diagnostic solutions…{post_date: F d, Y}
Anumana and Pfizer Partner to Enable Early Detection of Underdiagnosed Cardiovascular Disease
Companies initiate research agreement supporting development of new AI-ECG algorithm to help identify patients who may be at risk of cardiac amyloidosis{post_date: F d, Y}
Trial demonstrates early AI-guided detection of heart disease in routine practice
Science Daily: Heart disease can take a number of forms, but some types of heart disease, such as asymptomatic low ejection fraction, can be hard to recognize, especially in the…{post_date: F d, Y}